About Index Trending news
Analyze
Pricing
Respicardia, Inc.

Respicardia, Inc.

Respicardia, Inc.

Respicardia develops implantable therapies to improve respiratory andcardiovascular health.

Elsewhere

Alexa global traffic share

Latest funding
Debt financing
$5,100,000
Sorin Group
Convertible Note
$2,003,994
Employees

Unknown size

Locations
HQ
Headquarters
$5,100,000 Debt financing
Twin Cities Business

Respicardia Raises $5.1M After Positive Results in Sleep Apnea Trial